Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

CancerCare

CharityWatch report issued
August 2022

Top-Rated Charity
A+
CharityWatch Grade
Our independent grade based
on a number of factors.
 
94%
Program Percentage
Amount spent on programs
relative to overhead.
 
$4
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

CancerCare
275 Seventh Avenue
New York, NY 10001

Other Names

Cancer Care Co-Payment Assistance Foundation

Tax Status

501(c)3

Stated Mission

To improve lives by helping people cope with, and manage, the emotional and practical challenges of cancer.

View similar charities
Charity  
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America (DISSOLVED)  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation (DISSOLVED)  
Children's Cancer Research Fund  
Children's Leukemia Research Association  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation / Stand Up To Cancer  
Good Charity (DISSOLVED)  
Leukemia & Lymphoma Society  
Livestrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Breast Cancer Foundation  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 06/30/2021

Program Percentage: 94%

The percentage of CancerCare's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$95,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $4

How many dollars CancerCare spends on fundraising to raise each $100 of contributions.

$87,000,000

Calculated Total Contributions

(rounded)

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
Cancer Care IRS Form 990 13-1825919
Cancer Care Co-Payment Assistance Foundation IRS Form 990 26-1196709
Cancer Care Audited Consolidated Financial Statements multiple
Entity: Cancer Care
Document Type: IRS Form 990
Tax ID: 13-1825919
Entity: Cancer Care Co-Payment Assistance Foundation
Document Type: IRS Form 990
Tax ID: 26-1196709
Entity: Cancer Care
Document Type: Audited Consolidated Financial Statements
Tax ID: multiple

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
CancerCare
meets governance benchmarks.
 
CancerCare
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy

  Name Title Compensation
1 Patricia Goldsmith CEO $458,422
2 Christine Verini COO $396,720
3 John Rutigliano Chief Financial & Compliance Officer $348,228
1
Name: Patricia Goldsmith
Title: CEO
Compensation: $458,422
2
Name: Christine Verini
Title: COO
Compensation: $396,720
3
Name: John Rutigliano
Title: Chief Financial & Compliance Officer
Compensation: $348,228

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

CharityWatch's rating of Cancer Care also includes the financial activities of Cancer Care Co-Payment Assistance Foundation, which are consolidated in the Cancer Care audited financial statements for the fiscal year ended June 30, 2021. Each entity is organized as a 501(c)(3) public charity. All intercompany transactions have been eliminated in the audit consolidation.


According to the Cancer Care consolidated audit of June 30, 2021 (Note 1 re: Organization):

"On July 23, 2007, Cancer Care incorporated the Cancer Care Co-Payment Assistance Foundation, Inc. (the Co-Pay Foundation)... The primary function of the Co-Pay Foundation is to provide financial assistance to individuals with cancer in the form of copayment assistance for both prescribed treatment and supporting medications, premium assistance, or other direct financial assistance in order to ensure access to care, treatment, and prescribed medications."

According to the Cancer Care consolidated audit of June 30, 2021 (Note 1(d) re: Contributions), the Organization reports receiving approximately $69.0 million in "Contributions from the five largest donors," representing 77% of total contributions, in fiscal 2021.

According to the Cancer Care consolidated audit of June 30, 2021 (Note 1(e) re: Contributed Goods and Services), Cancer Care received contributed goods and services in fiscal 2021 on which it placed a total value of $1,938,492.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to the Cancer Care consolidated audit of June 30, 2021 (Note 11, Payroll Protection Program Refundable Advance):

"On March 11, 2020, the World Health Organization designated COVID-19 as a pandemic. In April 2020, the Organization received funding from the Coronavirus Aid, Relief, and Economic Security (CARES) Act through the Payroll Protection Program. Funding through this program consists of loans that are designed to provide a direct incentive for small businesses to keep their workers on payroll. These loans will be forgiven if certain criteria are met and the funds are used for eligible expenses.

"The Organization applied for and received a Payroll Protection Program Loan in April 2020 in the amount of $1,861,575. Any portion of the loan that is not forgiven will be assessed at a 1% interest rate payable over a five-year period. The loan is recorded in the [audited] consolidated balance sheet in Payroll Protection Program refundable advance as of June 30, 2021. The Organization applied for complete forgiveness in accordance with the provisions for loan forgiveness in July 2021 and the application for forgiveness was approved in September 2021."

According to the Cancer Care consolidated audit of June 30, 2021 (Note 12, COVID-19 Impact):

"As a result of the COVID-19 pandemic, economic uncertainties have arisen, which may negatively affect the balance sheet, results of operations, and cash flows of the Organization. The duration of these uncertainties and the ultimate financial effects cannot be reasonably estimated at this time."

According to the Cancer Care tax filing for the fiscal year ended June 30, 2021, Cancer Care reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III):

Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, line 7):

"The organization from time-to-time will make performance-based bonus payments. For key employees those amounts are determined in conjunction with the president of the board and executive committee. Key employees may award bonuses, within the parameters of the organization's human resources compensation program, to staff. In limited amounts all employees are eligible for years of service bonuses when reaching service levels in 5-year increments."


Cancer Care reports "Bonus & incentive compensation" payments to six individuals in calendar year 2020, including $65,000 and $40,250 to Patricia Goldsmith, Chief Executive Officer, and Christine Verini, Chief Operating Officer, respectively. Their reported total compensation in 2020 is $458,422 and $396,720, respectively. In addition, one individual received "Bonus & incentive compensation" in the amount of $20,000, and the remaining three individuals received "Bonus & incentive compensation" that ranged from $5,250 to $1,000. The reported total compensation in 2020 for those four individuals ranged from $348,228 to $209,534 (IRS Form 990, Schedule J, Part II).


Related Articles

No related articles found